Breast Cancer Therapy
Optimal management of ductal carcinoma in situ of the breast described
Published in Cancer Weekly, May 25th, 2004
"Ductal carcinoma in situ (DCIS) represents a breast lesion that is diagnosed with increasing frequency, mainly due to the wide use of screening mammography. Today, DCIS comprises 15-25% of all breast cancers detected at population screening programs. Consequently, the concepts of properly managing such patients assume a greater importance in everyday practice," scientists in Greece and the United States report.
"Mammographically detected microcalcifications are the most common presentation of DCIS," said...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-05-25)
More Articles from Cancer Weekly
- Acute Myeloid Leukemia
A combined regimen is active against refractory acute myelogenous leukemia - Brain Cancer
Irinotecan plus BCNU shows low toxicity in patients with progressive glioma - Cancer Risk Factor
Nitrites consumed from animal products may increase pancreatic cancer risk - Public Health
Drinking water wells near abandoned mines need to be tested for carcinogens - AIDS/HIV Transmission
AZT causes pattern of mutations in Tk gene of mice treated as neonates - Actinic Keratosis
Phase II clinical trial of Polyphenon E Ointment begins - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
